In female BALB/c mice with intraperitoneal E. coli infection, oral Methacycline monotherapy at 20 mg/kg increased survival from 20.00% in solvent-treated controls to 40.00%. In the liver inflammation study, infected female BALB/c mice received oral Methacycline at 10 mg/kg; neither methacycline nor plumbagin treatment notably reduced inflammation. [2,3]
Survival in an intraperitoneal bacterial infection model
Animal study · Female BALB/c mice, aged 6–8 weeks; intraperitoneal infection model; E. coli 47EC; n = 15 per group [2]
Female BALB/c mice with intraperitoneal E. coli infection received oral Methacycline monotherapy at 20 mg/kg once every 12 h. Survival increased from 20.00% in solvent-treated controls to 40.00% with Methacycline.
Conditions shared by the study groups
- Route
- orally fed
- Treatment course
- once every 12 h
- Vehicle
- 0.5% CMC-Na
- Methacycline 20 mg/kg
- Model: Female BALB/c mice, aged 6–8 weeks; intraperitoneal infection model; E. coli 47EC; n = 15 per group
Methods and source locations
Compound reported in the paper: Methacycline
The paper names Methacycline without stating the salt or form; not verified as the hydrochloride form supplied as A10574. No dose conversion or lot validation.
Materials and methods > Bacterial strains and reagents (S8); Materials and methods > Mouse infection model assays (S57, S59); Results > The combination of mefloquine and methacycline effectively protected mice from intraperitoneal infections caused by E. coli (S139)
survival rate: survival rate; comparator: solvent-treated, control — Results > The combination of mefloquine and methacycline effectively protected mice from intraperitoneal infections caused by E. coli (S139)
Methacycline 20 mg/kg · Materials and methods > Mouse infection model assays (S59); Results > The combination of mefloquine and methacycline effectively protected mice from intraperitoneal infections caused by E. coli (S139)
Liver inflammation in infected mice
Animal study · Female BALB/c mice (6-8 weeks old) [3]
Infected female BALB/c mice received Methacycline orally at 10 mg/kg every 12 h, with infected solvent-treated mice serving as controls. Neither methacycline nor plumbagin treatment notably reduced inflammation.
Conditions shared by the study groups
- Route
- oral administration
- Treatment course
- every 12 h
- Vehicle
- control solvent
- Methacycline 10 mg/kg
- Model: Female BALB/c mice (6-8 weeks old)
Methods and source locations
Compound reported in the paper: Methacycline
The paper names Methacycline without stating the salt or form; not verified as the hydrochloride form supplied as A10574. No dose conversion or lot validation.
Methods > Mice infection assays (S78, S80, S81); Results > Plumbagin in combination with tetracyclines synergistically protected mice from systemic infection (S217, S222, S224)
The production of the inflammatory mediators interleukin IL-6 (d), IFN-γ (e) and tumour necrosis factor (TNF)-α (f) in the liver: The production of the inflammatory mediators interleukin IL-6 (d), IFN-γ (e) and tumour necrosis factor (TNF)-α (f) in the liver; comparator: The infected mice treated with control solvent served as controls. — Results > Plumbagin in combination with tetracyclines synergistically protected mice from systemic infection (S217, S224)
Methacycline 10 mg/kg · Methods > Mice infection assays (S81); Results > Plumbagin in combination with tetracyclines synergistically protected mice from systemic infection (S217)